Integrity of randomized clinical trials: how to prevent research misconduct and ensure transparency
"Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. It is therefore...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Boca Raton ; London ; New York ; Abingdon, Oxon
CRC Press, Taylor & Francis Group
[2025]
|
| Ausgabe: | First edition |
| Schlagworte: | |
| Zusammenfassung: | "Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. It is therefore more important than ever that ethics, transparency and professionalism explicitly guide research integrity. Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at undergraduate nor at postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness and trustworthiness of clinical trials and filling a current void in the market. Key Features: The first book on clinical trial integrity. Provides clear guidance on how to ensure probity in peer review, appraisal of trials and investigation of complaints concerning misconduct in clinical trials. Trains and supports researchers globally in how to undertake trials with integrity. Ensures the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met. The book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, funders and regulators of clinical trials"-- |
| Beschreibung: | Includes bibliographical references |
| Beschreibung: | xiv, 198 Seiten Illustrationen |
| ISBN: | 9781032609867 9781032601229 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV050231093 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 250402s2025 xxua||| |||| 00||| eng d | ||
| 020 | |a 9781032609867 |c hardback |9 978-1-032-60986-7 | ||
| 020 | |a 9781032601229 |c paperback |9 978-1-032-60122-9 | ||
| 035 | |a (DE-599)KXP1912852438 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US |a xxk |c XA-GB | ||
| 049 | |a DE-19 | ||
| 082 | 0 | |a 174.2/8 |2 23 | |
| 100 | 1 | |a Khan, Khalid S. |e Verfasser |0 (DE-588)128883464 |4 aut | |
| 245 | 1 | 0 | |a Integrity of randomized clinical trials |b how to prevent research misconduct and ensure transparency |c Khalid S. Khan (Beatriz Galindo Distinguished Investigator, University of Granada, Spain) |
| 250 | |a First edition | ||
| 264 | 1 | |a Boca Raton ; London ; New York ; Abingdon, Oxon |b CRC Press, Taylor & Francis Group |c [2025] | |
| 264 | 4 | |c © 2025 | |
| 300 | |a xiv, 198 Seiten |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 505 | 8 | |a Randomized clinical trials -- Integrity of trials -- Ethics committee approval and participant consent -- Trial planning -- Trial oversight -- Publishing trials responsibly -- Authorship of trials -- Evidence syntheses of randomized clinical trials -- Investigating research misconduct allegations. | |
| 520 | 3 | |a "Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. It is therefore more important than ever that ethics, transparency and professionalism explicitly guide research integrity. Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at undergraduate nor at postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness and trustworthiness of clinical trials and filling a current void in the market. Key Features: The first book on clinical trial integrity. Provides clear guidance on how to ensure probity in peer review, appraisal of trials and investigation of complaints concerning misconduct in clinical trials. Trains and supports researchers globally in how to undertake trials with integrity. Ensures the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met. The book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, funders and regulators of clinical trials"-- | |
| 650 | 0 | 7 | |a Kontrollierte klinische Studie |0 (DE-588)4202997-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Methode |0 (DE-588)4038971-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Randomisierung |0 (DE-588)4280827-3 |2 gnd |9 rswk-swf |
| 653 | 0 | |a Randomized controlled trials as topic / Ethics | |
| 689 | 0 | 0 | |a Kontrollierte klinische Studie |0 (DE-588)4202997-1 |D s |
| 689 | 0 | 1 | |a Randomisierung |0 (DE-588)4280827-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Kontrollierte klinische Studie |0 (DE-588)4202997-1 |D s |
| 689 | 1 | 1 | |a Methode |0 (DE-588)4038971-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 776 | 0 | |o 10.1201/9781003461401 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-003-46140-1 |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-035565912 | |
Datensatz im Suchindex
| _version_ | 1828307201760952320 |
|---|---|
| adam_text | |
| any_adam_object | |
| author | Khan, Khalid S. |
| author_GND | (DE-588)128883464 |
| author_facet | Khan, Khalid S. |
| author_role | aut |
| author_sort | Khan, Khalid S. |
| author_variant | k s k ks ksk |
| building | Verbundindex |
| bvnumber | BV050231093 |
| contents | Randomized clinical trials -- Integrity of trials -- Ethics committee approval and participant consent -- Trial planning -- Trial oversight -- Publishing trials responsibly -- Authorship of trials -- Evidence syntheses of randomized clinical trials -- Investigating research misconduct allegations. |
| ctrlnum | (DE-599)KXP1912852438 |
| dewey-full | 174.2/8 |
| dewey-hundreds | 100 - Philosophy & psychology |
| dewey-ones | 174 - Occupational ethics |
| dewey-raw | 174.2/8 |
| dewey-search | 174.2/8 |
| dewey-sort | 3174.2 18 |
| dewey-tens | 170 - Ethics (Moral philosophy) |
| discipline | Philosophie |
| edition | First edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV050231093</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">250402s2025 xxua||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781032609867</subfield><subfield code="c">hardback</subfield><subfield code="9">978-1-032-60986-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781032601229</subfield><subfield code="c">paperback</subfield><subfield code="9">978-1-032-60122-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1912852438</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield><subfield code="a">xxk</subfield><subfield code="c">XA-GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">174.2/8</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Khan, Khalid S.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)128883464</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Integrity of randomized clinical trials</subfield><subfield code="b">how to prevent research misconduct and ensure transparency</subfield><subfield code="c">Khalid S. Khan (Beatriz Galindo Distinguished Investigator, University of Granada, Spain)</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton ; London ; New York ; Abingdon, Oxon</subfield><subfield code="b">CRC Press, Taylor & Francis Group</subfield><subfield code="c">[2025]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2025</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 198 Seiten</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Randomized clinical trials -- Integrity of trials -- Ethics committee approval and participant consent -- Trial planning -- Trial oversight -- Publishing trials responsibly -- Authorship of trials -- Evidence syntheses of randomized clinical trials -- Investigating research misconduct allegations.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. It is therefore more important than ever that ethics, transparency and professionalism explicitly guide research integrity. Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at undergraduate nor at postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness and trustworthiness of clinical trials and filling a current void in the market. Key Features: The first book on clinical trial integrity. Provides clear guidance on how to ensure probity in peer review, appraisal of trials and investigation of complaints concerning misconduct in clinical trials. Trains and supports researchers globally in how to undertake trials with integrity. Ensures the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met. The book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, funders and regulators of clinical trials"--</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kontrollierte klinische Studie</subfield><subfield code="0">(DE-588)4202997-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Methode</subfield><subfield code="0">(DE-588)4038971-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Randomisierung</subfield><subfield code="0">(DE-588)4280827-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Randomized controlled trials as topic / Ethics</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kontrollierte klinische Studie</subfield><subfield code="0">(DE-588)4202997-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Randomisierung</subfield><subfield code="0">(DE-588)4280827-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kontrollierte klinische Studie</subfield><subfield code="0">(DE-588)4202997-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Methode</subfield><subfield code="0">(DE-588)4038971-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2=" "><subfield code="o">10.1201/9781003461401</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-003-46140-1</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-035565912</subfield></datafield></record></collection> |
| id | DE-604.BV050231093 |
| illustrated | Illustrated |
| indexdate | 2025-04-02T16:00:20Z |
| institution | BVB |
| isbn | 9781032609867 9781032601229 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-035565912 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | xiv, 198 Seiten Illustrationen |
| publishDate | 2025 |
| publishDateSearch | 2025 |
| publishDateSort | 2025 |
| publisher | CRC Press, Taylor & Francis Group |
| record_format | marc |
| spelling | Khan, Khalid S. Verfasser (DE-588)128883464 aut Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency Khalid S. Khan (Beatriz Galindo Distinguished Investigator, University of Granada, Spain) First edition Boca Raton ; London ; New York ; Abingdon, Oxon CRC Press, Taylor & Francis Group [2025] © 2025 xiv, 198 Seiten Illustrationen txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references Randomized clinical trials -- Integrity of trials -- Ethics committee approval and participant consent -- Trial planning -- Trial oversight -- Publishing trials responsibly -- Authorship of trials -- Evidence syntheses of randomized clinical trials -- Investigating research misconduct allegations. "Today scientists are expected to be more accountable and transparent than at any time in history. Globally the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefit from the innovative contributions made by researchers. It is therefore more important than ever that ethics, transparency and professionalism explicitly guide research integrity. Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at undergraduate nor at postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness and trustworthiness of clinical trials and filling a current void in the market. Key Features: The first book on clinical trial integrity. Provides clear guidance on how to ensure probity in peer review, appraisal of trials and investigation of complaints concerning misconduct in clinical trials. Trains and supports researchers globally in how to undertake trials with integrity. Ensures the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met. The book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, funders and regulators of clinical trials"-- Kontrollierte klinische Studie (DE-588)4202997-1 gnd rswk-swf Methode (DE-588)4038971-6 gnd rswk-swf Randomisierung (DE-588)4280827-3 gnd rswk-swf Randomized controlled trials as topic / Ethics Kontrollierte klinische Studie (DE-588)4202997-1 s Randomisierung (DE-588)4280827-3 s DE-604 Methode (DE-588)4038971-6 s 10.1201/9781003461401 Erscheint auch als Online-Ausgabe 978-1-003-46140-1 |
| spellingShingle | Khan, Khalid S. Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency Randomized clinical trials -- Integrity of trials -- Ethics committee approval and participant consent -- Trial planning -- Trial oversight -- Publishing trials responsibly -- Authorship of trials -- Evidence syntheses of randomized clinical trials -- Investigating research misconduct allegations. Kontrollierte klinische Studie (DE-588)4202997-1 gnd Methode (DE-588)4038971-6 gnd Randomisierung (DE-588)4280827-3 gnd |
| subject_GND | (DE-588)4202997-1 (DE-588)4038971-6 (DE-588)4280827-3 |
| title | Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency |
| title_auth | Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency |
| title_exact_search | Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency |
| title_full | Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency Khalid S. Khan (Beatriz Galindo Distinguished Investigator, University of Granada, Spain) |
| title_fullStr | Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency Khalid S. Khan (Beatriz Galindo Distinguished Investigator, University of Granada, Spain) |
| title_full_unstemmed | Integrity of randomized clinical trials how to prevent research misconduct and ensure transparency Khalid S. Khan (Beatriz Galindo Distinguished Investigator, University of Granada, Spain) |
| title_short | Integrity of randomized clinical trials |
| title_sort | integrity of randomized clinical trials how to prevent research misconduct and ensure transparency |
| title_sub | how to prevent research misconduct and ensure transparency |
| topic | Kontrollierte klinische Studie (DE-588)4202997-1 gnd Methode (DE-588)4038971-6 gnd Randomisierung (DE-588)4280827-3 gnd |
| topic_facet | Kontrollierte klinische Studie Methode Randomisierung |
| work_keys_str_mv | AT khankhalids integrityofrandomizedclinicaltrialshowtopreventresearchmisconductandensuretransparency |